The US FDA has granted 510(k) clearance to NuvoAir’s Air Next Spirometer for in-home use as a full spirometer, enabling the expansion of the clinical operations to support patients with heart or lung conditions
Air Next can provide valuable clinical results to ensure continuous patient monitoring by performing full spirometry at home. These results help the clinical team to identify changes for immediate care before lung function deteriorates to the point of requiring hospitalization
Additionally, the 510(k) clearance enables the use of the Air Next Spirometer for ATS 2019-compliant spirometry in clinical studies throughout the US and the EU
Ref: Businesswire | Image: NuvoAir
Related News:- The US FDA Grants Breakthrough Device Designation to AbSolutions Med’s Rebuild Bioabsorbable Abdominal Wall Closure Device for Incisional Hernia
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
